A 45-year-old man with community-acquired pneumonia presents to the ICU with septic shock: BP 85/52 mmHg, HR 118/min, lactate 4.2 mmol/L. After fluid resuscitation (30 mL/kg crystalloid), his MAP remains 58 mmHg. The structure marked **A** in the diagram is initiated as the first-line vasopressor. Which of the following BEST explains why this agent is preferred over dopamine in septic shock according to current Surviving Sepsis Campaign Guidelines?

Explanation

## Why option 1 (Norepinephrine has predominant α1 activity with mild β1 effect, resulting in lower mortality and fewer arrhythmias compared to dopamine in septic shock) is correct The clinical anchor is that norepinephrine is the FIRST-LINE vasopressor in septic shock per Surviving Sepsis Campaign Guidelines, with predominant α1 activity (vasoconstriction → ↑ SVR → ↑ MAP) and mild β1 effect (modest inotropy). Meta-analyses including the SOAP-II trial demonstrate that norepinephrine is associated with LOWER MORTALITY and FEWER ARRHYTHMIAS compared to dopamine in septic shock. This pharmacodynamic profile—strong vasoconstriction without excessive β-mediated tachycardia—is the evidence-based rationale for preferring norepinephrine over dopamine in this setting (KD Tripathi 9e Ch 9; Harrison 21e Ch 297). ## Why each distractor is wrong - **Option 0 (Superior β1 selectivity)**: Norepinephrine is NOT β1-selective; it has PREDOMINANT α1 activity with only MILD β1 effect. Dobutamine is the β1-selective agent. This reversal of pharmacology is a common student error. - **Option 2 (Selective renal vasodilation)**: Norepinephrine does not cause selective renal vasodilation; it causes systemic vasoconstriction via α1. While adequate MAP (≥ 65 mmHg) supports renal perfusion, this is not the mechanism explaining superiority over dopamine. - **Option 3 (V1 receptor agonism)**: Vasopressin, not norepinephrine, works through V1 receptors. Vasopressin is added as a SECOND vasopressor if norepinephrine alone is insufficient. This is a distractor testing confusion between the two agents. **High-Yield:** Norepinephrine (α1 >> β1) is first-line in septic shock; dopamine is now reserved for bradycardia + hypotension unresponsive to atropine. SOAP-II trial: norepinephrine = lower mortality and fewer arrhythmias vs dopamine. [cite: KD Tripathi 9e Ch 9; Harrison 21e Ch 297; Surviving Sepsis Campaign Guidelines; SOAP-II trial]